• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

MGMA research reflects importance of transparent, standardized processes


Medical Group Management Association (MGMA) study highlights member satisfaction with major health plans.

Medical Group Management Association (MGMA), Englewood, Colo., has released results from its study of MGMA member satisfaction with major health plans. Respondents were most satisfied with the disclosure of payers’ fee schedules and prompt payment of claims. Administrative processes that were standardized and transparent also produced high satisfaction scores.

"Instead of pursuing one-off plan specific administrative processes, MGMA is strongly encouraging health plans to adopt standardized approaches in areas that include machine readable patient ID cards, and uniform companion guides and operating rules in support of HIPAA administrative transactions,” Anders M. Gilberg vice president, Public and Private Economic Affairs of MGMA tells Managed Healthcare Executive. “In addition, plans need to come together to provide Web-based, multi-payer solutions for real-time claims adjudication and eligibility verification. We assert there are no competitive advantages to a health plan adopting proprietary administrative processes. This only causes unnecessary redundancy and burdens for physician practices."

MGMA members expressed a high level of satisfaction with the major private health plans regarding their provider credentialing processes, but citied dissatisfaction with this process for Medicare.

“We believe this is result of Medicare’s refusal to participate in the standardized physician credentialing system (CAQH Universal Provider Datasource) that is widely used in the private sector,” says William F. Jessee, MD FACMPE, MGMA president CEO. “Our members appreciate payers that provide clear, consistent processes, especially processes that are based on industry-wide standards.”

MGMA members gave Medicare Part B highest marks on questions related to responsiveness, transparency, prompt payment and overall satisfaction with general administrative functions. “Despite the fact that Medicare consistently underpays and places member practices in an increasingly difficult financial situation - with a looming 21% cut to physician payments - MGMA members were positive about the standardized and predicable nature of how the program is administered,” says Jessee.

MGMA’s membership includes practice administrators, CEOs, physicians in management, board members and numerous other practice management professionals. MGMA represents group practices that are major suppliers of physician services for health plans.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
© 2024 MJH Life Sciences

All rights reserved.